Skip to main content
ADIMMUNE CORPORATION logo

ADIMMUNE CORPORATION — Investor Relations & Filings

Listed
Ticker · 4142 ISIN · TW0004142005 LEI · 549300M5TV8YGVXU1827 TW Manufacturing
Open in API
Filings indexed 1,813 across all filing types
Latest filing 2026-06-17 Annual Report
Country TW Taiwan
Listing TW 4142

About ADIMMUNE CORPORATION

http://www.adimmune.com.tw/

ADIMMUNE CORPORATION, established in 1965, specializes in the research, development, and large-scale manufacturing of human vaccines and biologics. The company is a primary supplier of seasonal influenza and tetanus vaccines, maintaining production facilities that adhere to PIC/S GMP, US FDA, and EU standards. Its operations encompass the full product lifecycle, from initial R&D to commercial distribution. In addition to its proprietary vaccine portfolio, the company provides Contract Development and Manufacturing Organization (CDMO) services, supporting collaborative development and global supply chains. Recognized for its technical expertise in viral and bacterial vaccine production, the organization focuses on delivering high-quality immunization solutions to international markets while leveraging its history as a pioneering vaccine laboratory.

Recent filings

Filing Released Lang Actions
115年年報及股東會資料 — 2026_4142_20260604F05.pdf
Annual Report Classification · 100% confidence The document contains detailed minutes of the 5th Annual General Meeting (AGM) of 國光生物科技股份有限公司 held on a certain date, including attendance details, chairman statements, agenda reports, resolutions, and voting results. It also includes comprehensive attachments such as the annual business report for the fiscal year 114 (Taiwan calendar), auditor's committee report, and the auditor's report by PricewaterhouseCoopers (PwC) for the fiscal year 114, all indicating full financial data including balance sheets, profit and loss statements, cash flow statements, and auditor opinions. The presence of the complete annual business report and full audited financial statements, which summarise the fiscal year activities and financial performance, identifies this document as an Annual Report equivalent filing. The document length and detail confirm this is not merely an announcement or summary but a full official yearly report, satisfying the criteria for classification as a 10-K type filing (Annual Report). FY 2025
2026-06-17 Chinese
115年年報及股東會資料 — 2025_4142_20260604FE4.pdf
Annual Report Classification · 100% confidence The document is titled "2025 Annual Report" of Adimmune Corporation and carries detailed information typical of a full annual report, including business operations, financial results, governance and management data, R&D activities, and comprehensive company data. The length exceeds 15,000 characters, which supports a full report rather than a brief announcement. References to fiscal year results and extensive content of various chapters align with a typical Annual Report (10-K equivalent). Therefore, based on the document's title, content depth, and structure, it is classified as an Annual Report (10-K). FY 2025
2026-06-17 English
115年年報及股東會資料 — 2025_4142_20260604F04.pdf
Annual Report Classification · 99% confidence The document is titled as the company's 114th annual report (年報) for the year ending April 30, 115 (Taiwan calendar year). It contains extensive financial analysis, operational results, future plans, company governance details including board and senior management bios, remuneration, shareholder information, audited financial results summary, capital raising, business overview, risk analysis, and other typical contents of a full annual report. The document is long (over 139,000 characters), consistent with detailed financial performance disclosure. There is no indication it is merely a presentation, announcement, or transcript. The content fits precisely the definition of an Annual Report (10-K), which is a yearly comprehensive report covering company activities and full financial performance. FY 2025
2026-06-17 Chinese
115年年報及股東會資料 — 2026_4142_20260604F17.pdf
Major Shareholding Notification Classification · 95% confidence The document lists details about the top ten shareholders, their shareholding percentages, and their relationships, such as familial and associated entities. It focuses on reporting the shareholding structure and relationships among major shareholders. This type of disclosure matches the definition of a Major Shareholding Notification, which typically reports changes or statuses of significant share ownership with relationship details. The document length is short (1157 characters) and does not include full financial statements or other types of reports. Therefore, based on the content, this filing corresponds to Major Shareholding Notification (MRQ).
2026-06-17 Chinese
115年5月背書保證與資金貸與
Regulatory Filings Classification · 85% confidence The document is a regulatory disclosure of the company’s and its subsidiaries’ loan exposure and endorsement/guarantee balances submitted to the “公開資訊觀測站” (Public Information Observatory). It contains tables of actual financial data on guarantees but is not a full financial report (e.g., annual or interim), nor an announcement of a meeting or capital change. It is a standard compliance filing of specific guarantee information, fitting the catch‐all ‘Regulatory Filings’ category.
2026-06-09 Chinese
115年5月營業收入
Regulatory Filings Classification · 85% confidence The document is a monthly operating revenue summary (“查詢彙總報表”) from the Taiwan MOPS site, showing current and year-to-date net sales vs. prior year figures. It is not a full interim or annual report but a routine regulatory submission of monthly revenue data. There’s no detailed quarterly financial statements or management discussion, nor is it an announcement of publication; it is the actual data submission required by regulators. Therefore it falls under general Regulatory Filings (RNS).
2026-06-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.